Illumina's over the next few years are expected to double, indicating a very optimistic future ahead.
With less than 0.02% of humans having been sequenced and 99% of the variants discovered in the genome having not yet been deciphered, Illumina , at only $3.4 billion of TTM revenue, is still in its infancy in what is potentially a greater than $50 billion genetics analysis tools market opportunity. (insidermonkey.com)
12/17/2020 BTIG Research Upgrade Neutral ➝ Buy $410.00
The indicators are on most timeframes!
If you are interested to test some amazing BUY and SELL INDICATORS that i use, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
My Best Stock Picks: https://www.patreon.com/tradingindicators